Role evidence
Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 4
Treatment-assignment count: 0
Stratification count: 0
Trial Selection Rising
HER2 / ERBB2 expression
solid tumor basket · Immune Checkpoint Inhibitor
HER2 / ERBB2 expression is flagged as trial selection rising because public trials show inclusion required evidence in 5 contexts. FDA CDx context should be reviewed manually.
Threshold snippets
Fragmentation view
Threshold count: 1
Common snippets: MSI-H
Threshold label: Low
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Manual Review Required
CDx maturity score: 2/5
Confidence: Medium
Patent-density signal
Diagnostic appendix
Signal count: 0
Recent signals: 0
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT05934331 | https://clinicaltrials.gov/study/NCT04879368 | https://clinicaltrials.gov/study/NCT05727410 | https://clinicaltrials.gov/study/NCT07213557 | https://clinicaltrials.gov/study/NCT05584670